1. Wang, Jincheng, Li, Weike, Li, Zimeng, Li, Fei, Qiu, Zilong. 2023. Taok1 haploinsufficiency leads to autistic-like behaviors in mice via the dorsal raphe nucleus. In Cell reports, 42, 113078. doi:10.1016/j.celrep.2023.113078. https://pubmed.ncbi.nlm.nih.gov/37656623/
2. Song, Mengqiu, Qu, Yingzi, Jia, Huajie, Lee, Mee-Hyun, Dong, Zigang. 2024. Targeting TAOK1 with resveratrol inhibits esophageal squamous cell carcinoma growth in vitro and in vivo. In Molecular carcinogenesis, 63, 991-1008. doi:10.1002/mc.23703. https://pubmed.ncbi.nlm.nih.gov/38376345/
3. Du, Gang, Jiang, Zhaochen, Xia, Tong, Zhai, Xiangyu, Jin, Bin. 2024. lincRNA00907 promotes NASH progression by targeting miRNA-942-5p/TAOK1. In Aging, 16, 6868-6882. doi:10.18632/aging.205730. https://pubmed.ncbi.nlm.nih.gov/38613803/
4. Chen, Lian. 2022. TAOK1 Promotes Proliferation and Invasion of Non-Small-Cell Lung Cancer Cells by Inhibition of WWC1. In Computational and mathematical methods in medicine, 2022, 3157448. doi:10.1155/2022/3157448. https://pubmed.ncbi.nlm.nih.gov/36158126/
5. Xia, Ying, Andersson, Emma, Anand, Sumit K, Blüher, Matthias, Mahlapuu, Margit. 2023. Silencing of STE20-type kinase TAOK1 confers protection against hepatocellular lipotoxicity through metabolic rewiring. In Hepatology communications, 7, . doi:10.1097/HC9.0000000000000037. https://pubmed.ncbi.nlm.nih.gov/36930872/